Gregory Downey serves as Executive at Lexaria Bioscience Corp., where they oversee executive responsibilities. Since joining the company, Gregory Downey has executed 2 insider transactions totaling $253, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 14, 2022 involved receiving (via award) 121 shares valued at $253.
Gregory Downey currently holds 1,954 shares of Lexaria Bioscience Corp. (LEXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Downey has been a net buyer of LEXX stock. They have purchased $253 and sold $0 worth of shares.
Gregory Downey's most recent insider trade was on Oct 14, 2022, when they sold 121 shares at $2.09 per share.
Get notified when new Form 4 filings are submitted
| $2.09 |
| Discretionary |